Biotech Currents

Biotech Currents

Share this post

Biotech Currents
Biotech Currents
Phase II data could drive SpringWorks' Ogsiveo (nirogacestat) to approval in second indication | $SWTX

Phase II data could drive SpringWorks…

Bill Langbein
Aug 19, 2024

Share this post

Biotech Currents
Biotech Currents
Phase II data could drive SpringWorks' Ogsiveo (nirogacestat) to approval in second indication | $SWTX

This thread is only visible to paid subscribers of Biotech Currents

Subscribe to view →

Comments on this post are for paid subscribers

Already a paid subscriber? Sign in
© 2025 Bill Langbein
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share